Lilian Orumana
Psychiatric/Mental Health · Phoenix, AZNPI 1457058091
Payments from drug & device makers
Across 184 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$531
- AbbVie$502
- Vanda Pharmaceuticals Inc.$356
- Alkermes, Inc.$280
- E.r. Squibb & Sons, L.L.C.$251
- Lundbeck LLC$243
- plus $2K from 13 others
What the payments were for
- Food & beverage$3,734100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $531 |
| AbbVie | 42 | $502 |
| Vanda Pharmaceuticals Inc. | 12 | $356 |
| Alkermes, Inc. | 11 | $280 |
| E.r. Squibb & Sons, L.L.C. | 10 | $251 |
| Lundbeck LLC | 11 | $243 |
| Teva Pharmaceuticals USA, Inc. | 15 | $239 |
| Almatica Pharma LLC | 10 | $234 |
| Axsome Therapeutics, Inc. | 9 | $232 |
| Biogen | 9 | $194 |
| Viiv Healthcare Company | 1 | $124 |
| Corium, LLC | 9 | $116 |
| Collegium Pharmaceutical, Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Neurocrine Biosciences, Inc. | 3 | $71 |
| Bausch Health US, LLC | 3 | $65 |
| Johnson & Johnson | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$103
How this compares
$3,734 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 11 | $183 |
| Hydroxyzine Pamoate | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.